We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.1B
AUM Growth
+$1.71B
(+9.3%)
Cap. Flow
-$319M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
575
New
91
Increased
134
Reduced
234
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$215M |
| 2 |
Apple
AAPL
|
+$134M |
| 3 |
Microchip Technology
MCHP
|
+$131M |
| 4 |
T-Mobile US
TMUS
|
+$120M |
| 5 |
Cognizant
CTSH
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 2 |
NXP Semiconductors
NXPI
|
+$164M |
| 3 |
Newell Brands
NWL
|
+$164M |
| 4 |
Biogen
BIIB
|
+$148M |
| 5 |
Electronic Arts
EA
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Communication Services | 18.63% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Financials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
351
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $605K | ﹤0.01% |
5,000
+500
| +11% | +$61.3K |
|
352
Credicorp
BAP
$30.9B
| $601K | ﹤0.01% |
3,680
+1,480
| +67% | +$243K |
|
|
GBT
353
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $590K | ﹤0.01% |
16,000
+4,000
| +33% | +$101K |
|
354
West Pharmaceutical
WST
$23.1B
| $571K | ﹤0.01% |
7,000
-1,250
| -15% | -$105K |
|
|
SAGE
355
DELISTED
Sage Therapeutics
SAGE
| $569K | ﹤0.01% |
+8,000
| New | +$469K |
|
|
KITE
356
DELISTED
Kite Pharma, Inc.
KITE
| $549K | ﹤0.01% |
+7,000
| New | +$433K |
|
357
Adecoagro
AGRO
$1.53B
| $525K | ﹤0.01% |
45,778
-12,815
| -22% | -$151K |
|
|
TTM
358
DELISTED
Tata Motors Limited
TTM
| $506K | ﹤0.01% |
14,200
-2,410
| -15% | -$88.1K |
|
359
Supernus Pharmaceuticals
SUPN
$2.68B
| $501K | ﹤0.01% |
16,000
+6,000
| +60% | +$161K |
|
|
HIND
360
Vyome Holdings
HIND
$14.5M
| – | – |
0
| – | – |
|
|
FOLD
361
DELISTED
Amicus Therapeutics
FOLD
| $499K | ﹤0.01% |
70,000
+10,000
| +17% | +$63.2K |
|
362
Trimble
TRMB
$12.3B
| $472K | ﹤0.01% |
14,753
-20,213
| -58% | -$625K |
|
363
Chevron
CVX
$388B
| $450K | ﹤0.01% |
4,190
-500
| -11% | -$56.1K |
|
|
CVA
364
DELISTED
Covanta Holding Corporation
CVA
| $437K | ﹤0.01% |
27,828
-4,747
| -15% | -$74.6K |
|
|
FPRX
365
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $434K | ﹤0.01% |
12,000
-3,000
| -20% | -$132K |
|
|
DBVT
366
DBV Technologies
DBVT
$807M
| $428K | ﹤0.01% |
1,215
| – | – |
|
367
Grupo Aeroportuario del Sureste
ASR
$8.03B
| $411K | ﹤0.01% |
+2,370
| New | +$367K |
|
368
New Oriental
EDU
$7.84B
| $400K | ﹤0.01% |
6,618
-3,207
| -33% | -$163K |
|
|
RARX
369
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $383K | ﹤0.01% |
18,000
+3,346
| +23% | +$64K |
|
370
HCA Healthcare
HCA
$84.8B
| $375K | ﹤0.01% |
4,215
-725
| -15% | -$60.5K |
|
371
GeoPark
GPRK
$649M
| $372K | ﹤0.01% |
+51,987
| New | +$285K |
|
372
Xylem
XYL
$28.5B
| $337K | ﹤0.01% |
6,701
-11,337
| -63% | -$553K |
|
373
Woodward
WWD
$25B
| $326K | ﹤0.01% |
4,802
-3,434
| -42% | -$238K |
|
374
Aecom
ACM
$9.07B
| $320K | ﹤0.01% |
8,997
-5,588
| -38% | -$204K |
|
375
Medpace
MEDP
$16.8B
| $315K | ﹤0.01% |
+10,564
| New | +$341K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2017 Portfolio in Review
As of Q1 2017, Fred Alger Management held 575 positions worth $20.1B, up 9.3% from $18.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management's Q1 2017 filing shows 91 new, 134 increased, 234 reduced and 49 closed positions. Its largest new stake was Microchip Technology: 3,702,676 shares worth $137M. The largest sale was Alphabet (Google) Class C, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Communication Services and Healthcare.
- Fred Alger Management's largest Q1 2017 buy was Microchip Technology: 3,702,676 shares worth $137M.
- Fred Alger Management added most to Walt Disney in Q1 2017, an estimated $215M increase.
- Fred Alger Management's biggest Q1 2017 reduction was Alphabet (Google) Class C, cutting an estimated $387M.
- Fred Alger Management fully exited Terminix Global Holdings, Inc. in Q1 2017, selling an estimated $59M.
- Fred Alger Management's ten largest holdings make up 39% of its $20.1B portfolio in Q1 2017.
- Fred Alger Management opened 91 new positions and closed 49 in Q1 2017.
- Fred Alger Management's portfolio value rose 9.3% quarter-over-quarter to $20.1B.
Based on Fred Alger Management's 13F filing for Q1 2017, filed 15 May 2017.